Ibuprofen attenuates cardiopulmonary dysfunction by modifying vascular tone in endotoxemia

S. M. Heidemann, J. P. Ofenstein, A. P. Sarnaik

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Ibuprofen, a cyclooxygenase inhibitor, improves pulmonary and cardiovascular injury in endotoxemia. We studied the mechanism of the beneficial effects of ibuprofen in relation to production of inflammatory mediators which influence vascular tone in endotoxemia. Rats were randomly assigned to one of three groups: (1) control, (2) endotoxemia alone; and (3) ibuprofen pretreatment and endotoxemia. Plasma and lung lavage concentrations of tumor necrosis factor, thromboxane B2 (TXB2), leukotriene (LT) C4,D4,E4 and nitric oxide (NO) were determined over a 2 h period. Pretreatment with ibuprofen resulted in increased survival, and attenuation of pulmonary and cardiovascular dysfunction when compared to the rats receiving endotoxin alone. The marked elevation in plasma TXB2 concentration in endotoxemic rats was prevented by pretreatment with ibuprofen. Similarly, pretreatment with ibuprofen prevented the decrease in lung lavage NO levels in endotoxemic rats. The improved survival and cardiopulmonary protection in endotoxemic rats pretreated with ibuprofen appears to be related to decreased thromboxane production and preservation of endothelial production of nitric oxide.

Original languageEnglish
Pages (from-to)181-185
Number of pages5
JournalProstaglandins Leukotrienes and Essential Fatty Acids
Issue number3
StatePublished - Mar 1999


Dive into the research topics of 'Ibuprofen attenuates cardiopulmonary dysfunction by modifying vascular tone in endotoxemia'. Together they form a unique fingerprint.

Cite this